Delivery Order SPE2DR25D3013-SPE2DR26F6T7F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,538.36 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) on November 20, 2025, with an ultimate completion date of November 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a specific product delivery under...
- The Defense Logistics Agency awarded a delivery order valued at $19,097.35 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) on September 17, 2025, with completion expected by September 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a $5,928.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count units) on October 31, 2025, with a completion date of November 3, 2025. This competitively awarded, non-set-aside contract represents a small-value pharmaceutical procurement for military healthcare supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $1,914.67 delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Kerendia 10 mg tablets (30-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicles with the...
- The Defense Logistics Agency awarded a delivery order valued at $2,737.75 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on October 27, 2025, with a ceiling value of $1,466.44 and an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under AmerisourceBergen's existing pharmaceutical supply contract with DLA. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,109.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $4,290.06 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Kerendia 20 mg tablets (30-count) with a ceiling value of $1,038.89. This competitively awarded, firm fixed-price delivery order is not set-aside and is scheduled for completion by December 11, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $4,453.16 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) under a firm fixed price contract. The delivery order was issued on December 10, 2025, with an ultimate completion date of December 11, 2025, and represents a non-competitive, non-set-aside procurement. Performance of this order will be executed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6T7FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,658.96 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 3, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The work will be performed at the vendor's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle supports comprehensive global pharmaceutical supply operations for military healthcare programs, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The IDC enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen as a critical vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 12/1/25 |